-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
NKGen Biotech, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2021 to Q2 2024.
- NKGen Biotech, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$7.46M, a 12.8% decline year-over-year.
- NKGen Biotech, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$31.4M, a 12.9% increase year-over-year.
- NKGen Biotech, Inc. annual Operating Income (Loss) for 2023 was -$29.7M, a 22.2% decline from 2022.
- NKGen Biotech, Inc. annual Operating Income (Loss) for 2022 was -$24.3M, a 871% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)